These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37959715)

  • 21. Characterization of albendazole-randomly methylated-β-cyclodextrin inclusion complex and in vivo evaluation of its antihelmitic activity in a murine model of Trichinellosis.
    García A; Leonardi D; Vasconi MD; Hinrichsen LI; Lamas MC
    PLoS One; 2014; 9(11):e113296. PubMed ID: 25406084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (13)C and (15)N solid-state NMR studies on albendazole and cyclodextrin albendazole complexes.
    Ferreira MJ; García A; Leonardi D; Salomon CJ; Lamas MC; Nunes TG
    Carbohydr Polym; 2015 Jun; 123():130-5. PubMed ID: 25843843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Albendazole nanocrystals with improved pharmacokinetic performance in mice.
    Paredes AJ; Bruni SS; Allemandi D; Lanusse C; Palma SD
    Ther Deliv; 2018 Feb; 9(2):89-97. PubMed ID: 29325510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissolution/Permeation of Albendazole in the Presence of Cyclodextrin and Bile Salts: A Mechanistic In Vitro Study into Factors Governing Oral Bioavailability.
    Eriksen JB; Christensen SB; Bauer-Brandl A; Brandl M
    J Pharm Sci; 2022 Jun; 111(6):1667-1673. PubMed ID: 34808218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioavailability comparison between albendazole and albendazole sulphoxide in rats and man.
    Dominguez L; Fagiolino P; Gordon S; Manta E
    Farmaco; 1995 Oct; 50(10):697-702. PubMed ID: 8590577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition kinetics of albendazole and metabolites in laying hens.
    Bistoletti M; Alvarez L; Lanusse C; Moreno L
    J Vet Pharmacol Ther; 2013 Apr; 36(2):161-8. PubMed ID: 22533477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative plasma disposition kinetics of albendazole and its new benzimidazol prodrug in dog.
    Khalil Z; El Karbane M; Faouzi ME; Ansar M; Azougagh M; El Harti J; Taoufik J
    Ann Pharm Fr; 2016 Jan; 74(1):21-6. PubMed ID: 26530448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymol/cyclodextrin inclusion complex nanofibrous webs: Enhanced water solubility, high thermal stability and antioxidant property of thymol.
    Celebioglu A; Yildiz ZI; Uyar T
    Food Res Int; 2018 Apr; 106():280-290. PubMed ID: 29579928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ex vivo diffusion of albendazole and its sulfoxide metabolite into ascaris suum and Fasciola hepatica.
    Alvarez LI; Mottier ML; Sánchez SF; Lanusse CE
    Parasitol Res; 2001 Nov; 87(11):929-34. PubMed ID: 11728018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the Preparation, Characterization, and Solubility of 2-HP-β-Cyclodextrin-Meclizine HCl Inclusion Complexes.
    George S; Vasudevan D
    J Young Pharm; 2012 Oct; 4(4):220-7. PubMed ID: 23493156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
    Zuo Z; Tam YK; Diakur J; Wiebe LI
    J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Vitro and In Vivo Drug Interaction Study of Two Lead Combinations, Oxantel Pamoate plus Albendazole and Albendazole plus Mebendazole, for the Treatment of Soil-Transmitted Helminthiasis.
    Cowan N; Vargas M; Keiser J
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6127-33. PubMed ID: 27480864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioavailability of albendazole sulphoxide after netobimin administration in sheep: effects of fenbendazole coadministration.
    Merino G; Alvarez AI; Redondo PA; Garcia JL; Larrodé OM; Prieto JG
    Res Vet Sci; 1999 Jun; 66(3):281-3. PubMed ID: 10333473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of cyclodextrin inclusion complexes of the anti-HIV non-nucleoside reverse transcriptase inhibitor UC781.
    Yang H; Parniak MA; Isaacs CE; Hillier SL; Rohan LC
    AAPS J; 2008 Dec; 10(4):606-13. PubMed ID: 19089644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation.
    Semalty M; Panchpuri M; Singh D; Semalty A
    Curr Drug Discov Technol; 2014 Jun; 11(2):154-61. PubMed ID: 24188445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A nanocrystal-based formulation improves the pharmacokinetic performance and therapeutic response of albendazole in dogs.
    Paredes AJ; Litterio N; Dib A; Allemandi DA; Lanusse C; Bruni SS; Palma SD
    J Pharm Pharmacol; 2018 Jan; 70(1):51-58. PubMed ID: 29034951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation and in vitro studies on radioactive and nonradioactive albendazole-beta-cyclodextrin complex tablets.
    Cetin EO; Ilem D; Gundogdu E; Asikoglu M; Kirilmaz L
    Pharmazie; 2011 Sep; 66(9):672-6. PubMed ID: 22026122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and Pharmacokinetic Evaluation of Two Parenteral Formulations of Albendazole Using Prodrug and Cosolvent Approaches.
    Becerril-Vega J; Hernández-Campos A; González-Hernández I; Flores-Ramos M; Castillo R; Leyva-Gómez G; Mayet-Cruz L; Jung-Cook H
    AAPS PharmSciTech; 2023 Jul; 24(6):158. PubMed ID: 37498473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enantioselective analysis of albendazole sulfoxide in cerebrospinal fluid by capillary electrophoresis.
    Paias FO; Lanchote VL; Takayanagui OM; Bonato PS
    Electrophoresis; 2001 Sep; 22(15):3263-9. PubMed ID: 11589289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydroxy-Propil-β-Cyclodextrin Inclusion Complexes of two Biphenylnicotinamide Derivatives: Formulation and Anti-Proliferative Activity Evaluation in Pancreatic Cancer Cell Models.
    Iacobazzi RM; Cutrignelli A; Stefanachi A; Porcelli L; Lopedota AA; Di Fonte R; Lopalco A; Serratì S; Laquintana V; Silvestris N; Franco M; Cellamare S; Leonetti F; Azzariti A; Denora N
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32906812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.